Clinical Trial Update: Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating long-term persistence of immunity to Hepatitis B in adolescents previously vaccinated in infancy with Engerix-B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2016-03-02